Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study
Cancer Causes and Control, 12/29/08
Zhang Y et al. - In a trial to examine the relation of use of multivitamins as well as several single vitamin and mineral supplements to the risk of prostate cancer, it was found that long-term zinc intake from multivitamins or single supplements is associated with a doubling in risk of prostate cancer.
Methods- The relation of use of multivitamins and several single vitamin and mineral supplements to the risk of prostate cancer was examined among 1706 prostate cancer cases and 2404 matched controls using data from the hospital-based case–control surveillance study.
- Odds ratios (OR) and 95% confidence intervals (CI) for risk of prostate cancer were estimated using conditional logistic regression model.
- For use of multivitamins that did not contain zinc, the multivariable odds ratios of prostate cancer were 0.6 for 1–4 yrs, 0.8 for 5–9 yrs, and 1.2 for 10 yrs or more, respectively.
- Men who used zinc for 10 years or more, either in a multivitamin or as a supplement, had an approximately 2-fold increased risk of prostate cancer.
- Vitamin E, beta-carotene, folate, and selenium use were not significantly associated with increased risk of prostate cancer.
Related Articles
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 84%
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 84%
Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men
The Prostate, 11/19/09
Relevance Score: 83%
Genetic variation in DNA repair genes and prostate cancer risk: Results from a population-based study
Cancer Causes and Control, 11/18/09
Relevance Score: 83%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 83%
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
Evidence-based Complementary and Alternative Medicine , 12/02/09
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
Carcinogenesis, 12/01/09
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequency of CYP1B1 homozygous genotype 355T/T in prostate cancer families from Poland
European Journal of Cancer Prevention, 12/08/09
Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
Cancer Research, 12/08/09
Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk
Cancer Epidemiology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


